Business
Electromed, Inc. Announces Fiscal 2025 Third Quarter Results
NEW PRAGUE, Minn., May 13, 2025--Electromed, Inc. Announces Fiscal 2025 Third Quarter Results
About this update from Electromed, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/fa222398196cdc2fed1803ebd1cc3fc5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Fhk27d5HClBtO918xx6zgA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/fa222398196cdc2fed1803ebd1cc3fc5","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/ukO7qgPEQL1WBlsk4eCAbA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/fa222398196cdc2fed1803ebd1cc3fc5","width":1024,"height":512}},"lazy":false},{"type":"text","content":"Strong operational execution results in tenth consecutive quarter of year-over-year revenue and net income growth","length":113,"tagName":"p","attribs":{}},{"type":"text","content":"NEW PRAGUE, Minn., May 13, 2025--(BUSINESS WIRE)--Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three and nine months ended March 31, 2025 ("Q3 FY 2025").","length":306,"tagName":"p"},{"type":"text","content":"Q3 FY 2025 Company Highlights","length":29,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net revenue increased 13.1% to $15.7 million in Q3 FY 2025, from $13.9 million in the third quarter of the prior fiscal year.","length":125,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Operating income increased to $2.1 million, a 16.2% increase from the third quarter of the prior fiscal year.","length":109,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Net income was $1.9 million, or $ 0.21 per diluted share, compared to $1.5 million, or $ 0.17 per diluted share in the third quarter of the prior fiscal year.","length":158,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Operating cash flow increased to $7.5 million for the nine months ended Q3 FY 2025, an increase of $3.0 million from the same period of the prior fiscal year.","length":158,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Electromed's board of directors approved a stock repurchase authorization of $5M in Q3 FY 2025."...